CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Current assets:
Cash	$ 500,962	$ 108,249
Accounts receivable, net	102,799	4,364
Inventory	37,776	44,996
Prepaid expenses and other assets	946,386	586,888
Total current assets	1,587,923	744,497
Property and equipment, net	299,910	337,361
Intellectual property and patents, net	1,206,011	900,472
Prepaid expenses and other assets	232,407
Other assets	69,837	117,555
Total assets	3,396,088	2,099,885
Current liabilities:
Accounts payable	774,387	544,980
Accrued expenses	508,733	129,978
Loan payable	105,125	50,425
Notes payable, net	920,000	800,000
Convertible promissory notes, net	5,242,431	1,551,488
Derivative liability	617,628	90,738
Deferred revenue	383,275	361,462
Total current liabilities	8,551,579	3,529,071
License Fees		560,000
Total liabilities	8,551,579	4,089,071
Stockholders' deficit:
Common stock: $0.001 par value; authorized 75,000,000 shares; 26,784,019 shares and 23,901,252 issued and outstanding as of December 31, 2018 and 2017, respectively	26,785	23,902
Additional paid-in capital	23,424,737	16,483,632
Stock payable	645,575	324,995
Accumulated deficit	(29,269,000)	(18,868,599)
Total CURE Pharmaceutical Holding Corp stockholders’ deficit	(5,171,903)	(2,036,070)
Noncontrolling interest	16,412	46,884
Total stockholders' deficit	(5,155,491)	(1,989,186)
Total liabilities and stockholders' deficit	$ 3,396,088	$ 2,099,885